Cargando…

Circulating prostaglandins as biomarkers for colorectal cancer?

Detalles Bibliográficos
Autores principales:	Greenhough, Alexander, Paraskeva, Chris, Williams, Ann C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484514/ https://www.ncbi.nlm.nih.gov/pubmed/26137550 http://dx.doi.org/10.1016/j.ebiom.2015.01.016

Ejemplares similares

The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells
por: Greenhough, Alexander, et al.
Publicado: (2010)

β-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin?
por: Smartt, H J M, et al.
Publicado: (2012)

Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance()()()
por: Li, Haitao, et al.
Publicado: (2014)

BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells
por: Legge, Danny N., et al.
Publicado: (2019)

BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor beta [TGF-β1] in colorectal tumour cells
por: Skeen, Victoria R., et al.
Publicado: (2012)

Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E(2)
por: Sampey, Annaleise V, et al.
Publicado: (2005)

PPAR-gamma Fun(gi) With Prostaglandin
por: Evans, Robert J., et al.
Publicado: (2020)

Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA
por: Montani, Francesca, et al.
Publicado: (2016)

Circulating protein and antibody biomarker for personalized cancer immunotherapy
por: Yuan, Jianda
Publicado: (2016)

BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling
por: Urban, Bettina C, et al.
Publicado: (2016)

Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells
por: Morgan, R G, et al.
Publicado: (2015)

Prostaglandin I(2) Receptor Agonism for Proteinuria and Diabetes: Good for the Goose and Good for the Gander?
por: Menon, Madhav C., et al.
Publicado: (2016)

Circulating microRNAs as Candidate Biomarkers for the Surveillance of Melanoma Patients
por: Behrmann, Iris, et al.
Publicado: (2015)

Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
por: Greenhough, Alexander, et al.
Publicado: (2018)

Deregulation of the circadian clock machinery: A novel biomarker for anti-angiogenic drug resistance in colorectal cancer
por: Della-Morte, David
Publicado: (2019)

CXCL1 induced by prostaglandin E(2) promotes angiogenesis in colorectal cancer
por: Wang, Dingzhi, et al.
Publicado: (2006)

The Hedgehog Inhibitor Cyclopamine Reduces β-Catenin-Tcf Transcriptional Activity, Induces E-Cadherin Expression, and Reduces Invasion in Colorectal Cancer Cells
por: Qualtrough, David, et al.
Publicado: (2015)

Circulating cell-free nucleic acids as potential biomarkers for sarcopenia: a step toward personalized medicine
por: Shafiee, Gita, et al.
Publicado: (2017)

Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients
por: Mirjačić Martinović, Katarina, et al.
Publicado: (2023)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Circulating epigenetic biomarkers for detection of recurrent colorectal cancer
por: Symonds, Erin L., et al.
Publicado: (2020)

Circulating tumor DNA for personalized lung cancer monitoring
por: Fiala, Clare, et al.
Publicado: (2017)

Circulating cancer stem cells: an interesting niche to explore
por: Papaccio, Federica
Publicado: (2020)

Prostaglandins and Cancer
por: Moore, K.
Publicado: (1983)

The Challenge of Metastatic Colorectal Cancer
por: Cidón, Esther Uña
Publicado: (2010)

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2019)

Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer
por: Yan, Shushan, et al.
Publicado: (2017)

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2017)

Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

Lung Cancer Early Detection: The Role of Circulating MicroRNAs
por: Bianchi, Fabrizio
Publicado: (2015)

New approaches for detecting cancer with circulating cell-free DNA
por: Fiala, Clare, et al.
Publicado: (2019)

Exploratory Evaluation of Neopterin and Chitotriosidase as Potential Circulating Biomarkers for Colorectal Cancer
por: Ciocan, Andra, et al.
Publicado: (2023)

Altered pathways and colorectal cancer prognosis
por: Moreno, Victor, et al.
Publicado: (2015)

Associations of Circulating Inflammatory Biomarkers with Risk Factors for Colorectal Cancer in Colorectal Adenoma Patients
por: Hopkins, Myfanwy H., et al.
Publicado: (2012)

Cancer biomarkers and targeted therapies
por: Shen, Zhiyuan
Publicado: (2013)

Recent translational research: circulating tumor cells in breast cancer patients
por: Müller, Volkmar, et al.
Publicado: (2006)

Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update
por: Jaén, Rafael I, et al.
Publicado: (2018)

The battle for prognosis at the invasive front of colorectal cancer
por: Lugli, Alessandro, et al.
Publicado: (2020)

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
por: El Sissy, Carine, et al.
Publicado: (2021)

Rural-urban difference in colorectal cancer mortality
por: Urakawa, Tomoya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3suratobf9tq6o5hacntruo38q